Pharmsville Co., Ltd. (KOSDAQ:318010)
South Korea · Delayed Price · Currency is KRW 3,450.00
+30.00 (0.88%)
At close: Jul 31, 2026
Pharmsville Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,877 | 12,728 | 16,725 | 21,395 | 26,113 | 39,028 |
Revenue Growth | -22.22% | -23.90% | -21.83% | -18.07% | -33.09% | -0.97% |
Gross Profit Gross Profit Growth | 7,500 | 8,045 | 10,501 | 13,142 | 15,823 | 25,762 |
Operating Income Operating Income Growth | -823.88 | -675.66 | -269.85 | 1,643 | 4,063 | 6,147 |
Net Income Net Income Growth | 2,989 | 2,889 | 1,583 | 3,310 | 4,063 | 5,000 |
Earnings Per Share EPS Growth | 386.70 | 373.77 | 205.00 | 422.59 | 517.79 | 637.00 |
EPS Growth | 60.47% | 82.33% | -51.49% | -18.38% | -18.71% | 73.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 39,525 | 39,105 | 37,676 | 39,546 | 42,835 | 41,735 |
Total Debt Total Debt Growth | 15.33 | 16.48 | 23.6 | 2,190 | 7,286 | 8,023 |
Net Cash (Debt) Net Cash Growth | 39,510 | 39,089 | 37,652 | 37,356 | 35,548 | 33,712 |
Net Cash Growth | 4.83% | 3.82% | 0.79% | 5.09% | 5.45% | 20.94% |
Net Cash Per Share Net Cash Per Share Growth | 5112.16 | 5058.01 | 4875.93 | 4770.04 | 4530.52 | 4296.44 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,520 | 1,894 | -346.56 | 4,651 | 5,203 | 8,273 |
Capital Expenditures CapEx Growth | -2.86 | -2.86 | -26.18 | -201.48 | -119.79 | -291.03 |
Free Cash Flow Free Cash Flow Growth | 1,517 | 1,891 | -372.74 | 4,450 | 5,083 | 7,982 |
Free Cash Flow Growth | - | - | - | -12.46% | -36.31% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 63.15% | 63.21% | 62.79% | 61.43% | 60.59% | 66.01% |
Operating Margin | -6.94% | -5.31% | -1.61% | 7.68% | 15.56% | 15.75% |
Pretax Margin | 31.70% | 28.21% | 10.94% | 18.54% | 19.88% | 15.79% |
Profit Margin | 25.16% | 22.69% | 9.46% | 15.47% | 15.56% | 12.81% |
FCF Margin | 12.77% | 14.86% | -2.23% | 20.80% | 19.47% | 20.45% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 200.000 | - | - | 100.000 | 100.000 | 100.000 |
Dividend Per Share Growth | 100.00% | - | - | 0% | 0% | 0% |
Dividend Yield | 5.80% | - | - | 1.26% | 1.01% | 0.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.92 | 9.19 | 18.28 | 20.34 | 21.05 | 21.50 |
Forward PE | - | 7.02 | 7.02 | 7.02 | 7.02 | 7.02 |
P/FCF Ratio | 17.57 | 14.04 | - | 15.13 | 16.82 | 13.47 |
PS Ratio | 2.24 | 2.09 | 1.73 | 3.15 | 3.28 | 2.75 |